These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 652058)

  • 1. A role of the polysynaptic system of substantia nigra in the cholinergic-dopaminergic equilibrium in the central nervous system.
    Wolfarth S; Dulska E; Gołembiowska-Nikitin K; Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Apr; 302(2):123-31. PubMed ID: 652058
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
    Wolfarth S
    Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
    [No Abstract]   [Full Text] [Related]  

  • 3. Stereotyped behaviour after cholinergic, but not dopaminergic, stimulation of the substantia nigra in rats.
    Decsi L; Nagy J; Zámbó K
    Life Sci; 1978 Jun; 22(21):1873-8. PubMed ID: 566832
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
    Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
    Neuropharmacology; 1977; 16(7-8):511-8. PubMed ID: 199852
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?
    Creese I; Iversen SD
    Psychopharmacol Bull; 1975 Oct; 11(4):12-3. PubMed ID: 1197588
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system.
    Pycock C; Milson J; Tarsy D; Marsden CD
    Neuropharmacology; 1978 Mar; 17(3):175-83. PubMed ID: 565479
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis.
    Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Rosales MG; Aceves J
    Neuroscience; 1994 Sep; 62(2):441-7. PubMed ID: 7830890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acetylcholine in the striatum. Recent insights and therapeutic implications.
    Benarroch EE
    Neurology; 2012 Jul; 79(3):274-81. PubMed ID: 22802594
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of electrical stimulation of the nigrostriatal pathway of the rat on dopamine metabolism.
    Korf J; Grasdijk L; Westerink BH
    J Neurochem; 1976 Mar; 26(3):579-84. PubMed ID: 1262880
    [No Abstract]   [Full Text] [Related]  

  • 10. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 11. Two kinds of nigrostriatal asymmetry: relationship to dopaminergic drug sensitivity and 6-hydroxydopamine lesion effects in Long-Evans rats.
    Glick SD; Hinds PA; Baird JL
    Brain Res; 1988 May; 450(1-2):334-41. PubMed ID: 3135915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the behavioural effects of infusion of carbachol and acetylcholinesterase into the rat substantia nigra.
    Hawkins CA; Greenfield SA
    Pharmacol Biochem Behav; 1996 Sep; 55(1):67-80. PubMed ID: 8870040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinergic stimulation of substantia nigra: abolition of carbachol-induced eating by unilateral 6-hydroxydopamine lesion of nigrostriatal dopamine neurones.
    Parker GC; Rugg EL; Winn P
    Exp Brain Res; 1991; 87(3):597-603. PubMed ID: 1723691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of dopamine in the substantia nigra after antidromic activation.
    Korf J; Zieleman M; Westerink BH
    Brain Res; 1977 Jan; 120(1):184-7. PubMed ID: 832118
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal cord dopaminergic neurons: evidence for an uncrossed nigrospinal pathway.
    Commissiong JW; Gentleman S; Neff NH
    Neuropharmacology; 1979 Jun; 18(6):565-8. PubMed ID: 481709
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].
    Costentin J
    Encephale; 1979; 5(2):121-49. PubMed ID: 38958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.